What is idiopathic pulmonary fibrosis?
Written in association with:
Pulmonologist
Published: 08/05/2024
Edited by: Conor Lynch
In this article below, established and well-respected consultant respiratory physician, Dr Tim Gatheral, provides us with an all-we-need-to-know guide with regards to idiopathic pulmonary fibrosis.
What is idiopathic pulmonary fibrosis?
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterised by the scarring and thickening of the lung tissue, which leads to a decline in lung function over time.
What causes the condition?
IPF primarily affects older adults, typically those over the age of 50, although it can occur at any age. The exact cause of IPF is not well understood, but it is believed to involve a combination of genetic predisposition, environmental factors, and abnormal wound healing processes in the lungs.
Smoking, exposure to certain environmental pollutants or occupational hazards, viral infections, and gastroesophageal reflux disease (GERD) have been suggested as potential risk factors for developing IPF, although not all individuals with these risk factors will develop the disease.
What are the main associated symptoms?
The hallmark symptom of IPF is progressive dyspnoea (shortness of breath), which worsens over time and is often accompanied by a persistent dry cough. Other common symptoms may include fatigue, weight loss, chest discomfort or tightness, and clubbing of the fingers or toes (enlargement and rounding of the fingertips or toes). IPF can significantly impact quality of life and daily activities, leading to functional limitations and reduced exercise tolerance.
How is idiopathic pulmonary fibrosis diagnosed?
Diagnosing IPF can be challenging, as the symptoms are non-specific and can mimic those of other lung diseases. A thorough medical history, physical examination, and diagnostic tests such as pulmonary function tests, high-resolution computed tomography (HRCT) scans, and rarely lung biopsies may be necessary to confirm the diagnosis and rule out other potential causes of pulmonary fibrosis.
What are the treatment options?
Treatment for IPF aims to slow disease progression, relieve symptoms, and improve quality of life. While there is currently no cure for IPF, several medications, including pirfenidone and nintedanib, have been approved for the treatment of IPF and have been shown to slow the decline in lung function and reduce the risk of disease progression.
Oxygen therapy, pulmonary rehabilitation, and lung transplantation may also be considered for individuals with advanced IPF or severe symptoms.
In addition to medical treatment, lifestyle modifications such as smoking cessation, avoiding environmental pollutants or respiratory irritants, and staying physically active can help manage symptoms and improve overall health in individuals with IPF. Regular monitoring and follow-up care with a healthcare provider experienced in managing IPF are essential for optimising treatment outcomes and addressing any changes in symptoms or lung function over time.
To schedule in an appointment with Dr Tim Gatheral today, simply visit his Top Doctors profile.